These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19179632)

  • 1. Consumer medication leaflets inadequate, FDA says.
    Traynor K
    Am J Health Syst Pharm; 2009 Feb; 66(3):208, 210. PubMed ID: 19179632
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisapride and patient information leaflets.
    Sukkari SR; Sasich LD
    CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
    [No Abstract]   [Full Text] [Related]  

  • 3. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation.
    Raynor DK; Svarstad B; Knapp P; Aslani P; Rogers MB; Koo M; Krass I; Silcock J
    J Am Pharm Assoc (2003); 2007; 47(6):717-24. PubMed ID: 18032134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical review of FDA-approved Medication Guides.
    Wolf MS; Davis TC; Shrank WH; Neuberger M; Parker RM
    Patient Educ Couns; 2006 Sep; 62(3):316-22. PubMed ID: 16884888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 6. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
    Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
    Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on medication guides.
    Park LM; Jones PR; Pearsall BM; Araojo RT
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):129-132. PubMed ID: 29280228
    [No Abstract]   [Full Text] [Related]  

  • 8. Using alternative methodologies for evaluating patient medication leaflets.
    Krass I; Svarstad BL; Bultman D
    Patient Educ Couns; 2002 May; 47(1):29-35. PubMed ID: 12023098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Educating patients about their medications: the potential and limitations of written drug information.
    Shrank WH; Avorn J
    Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of consumer medication information in the United States, Europe, and Australia.
    Stockigt JR
    J Am Pharm Assoc (2003); 2008; 48(3):326; author reply 326, 331. PubMed ID: 18595818
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA's Rx for better medication information.
    Farley D
    FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discussion continues on content, format of consumer drug leaflets.
    Traynor K
    Am J Health Syst Pharm; 2014 Aug; 71(16):1332-4. PubMed ID: 25074947
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug information leaflets for consumers need improvement, FDA says.
    Traynor K
    Am J Health Syst Pharm; 2002 Aug; 59(16):1498, 1501. PubMed ID: 12185823
    [No Abstract]   [Full Text] [Related]  

  • 14. Private-sector plan for patient information approved.
    Am J Health Syst Pharm; 1997 Feb; 54(4):352, 354. PubMed ID: 9043553
    [No Abstract]   [Full Text] [Related]  

  • 15. Written medicine information from English-speaking countries--how does it compare?
    Luk A; Tasker N; Raynor DK; Aslani P
    Ann Pharmacother; 2010 Feb; 44(2):285-94. PubMed ID: 20103613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA proposes that patient package insert program be rescinded.
    Hospitals; 1982 Feb; 56(4):84. PubMed ID: 7054117
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
    Rollema C; van Roon EM; Schilder AG; de Vries TW
    BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaesthetic drug information leaflets - for the patient or for the doctor?
    Bamgbade O
    Anaesthesia; 2001 Dec; 56(12):1213-4. PubMed ID: 11766682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.